Pharmacologically triggered hydrogel for scheduling hepatitis B vaccine administration

Area of Science:

• Biomaterials Science
• Vaccinology
• Pharmacology

Background:

• Current vaccine administration, particularly for hepatitis B, often requires multiple doses, posing challenges for public health coverage.
• Depot-based systems offer a promising strategy to simplify vaccine regimens and improve patient compliance.

Purpose of the Study:

• To develop and evaluate a novel biohybrid hydrogel depot for controlled release of a hepatitis B vaccine.
• To investigate the efficacy of oral stimulus-triggered vaccine release for immunization.

Main Methods:

• Subcutaneous implantation of a novobiocin-sensitive biohybrid hydrogel vaccine depot in a mouse model.
• Oral administration of the stimulus molecule novobiocin to trigger vaccine release.
• Assessment of immunization success post-vaccine administration.

Main Results:

• Successful subcutaneous implantation and controlled release of the hepatitis B vaccine from the hydrogel depot.
• Effective immunization of mice following oral administration of novobiocin.
• Demonstration of a novel, stimulus-responsive vaccination strategy.

Conclusions:

• Novobiocin-sensitive biohybrid hydrogels can serve as effective depots for controlled vaccine release.
• Stimulus-triggered oral vaccine delivery presents a viable alternative to traditional injections, potentially improving vaccination coverage.
• This approach offers a promising solution to overcome barriers in vaccine administration for hepatitis B and potentially other vaccines.